Comparing SunocoCorp (NYSE:SUNC) & Hypha Labs (OTCMKTS:DIGP)

Hypha Labs (OTCMKTS:DIGP) and SunocoCorp (NYSE:SUNC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares Hypha Labs and SunocoCorp’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hypha Labs	N/A	N/A	-35.56%
SunocoCorp	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Hypha Labs and SunocoCorp, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hypha Labs	0	0	0	0	0.00
SunocoCorp	1	0	0	0	1.00

Earnings and Valuation

This table compares Hypha Labs and SunocoCorp”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hypha Labs	$2.70 million	1.11	$250,000.00	N/A	N/A
SunocoCorp	N/A	N/A	N/A	N/A	N/A

Hypha Labs has higher revenue and earnings than SunocoCorp.

Summary

SunocoCorp beats Hypha Labs on 2 of the 3 factors compared between the two stocks.

About Hypha Labs

Hypha Labs, Inc., cultivates, produces, and sells psychedelic and functional mushroom in the United States. It has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

About SunocoCorp

Sunoco LP is an energy infrastructure and fuel distribution master limited partnership. Sunoco LP is based in DALLAS.